In one of the most challenging economic environments the industry has ever experienced, BayBio has responded by connecting entrepreneurs with traditional and new sources of capital. The region has a rich history of venture capital with deep ties to Silicon Valley, securing $2.33 billion in VC investment in 2011. The region also boasts a mature life science industry that has attracted investments from Wall Street as well as from pharmaceutical partners, now exceeding over $150 billion in market cap. As traditional venture capital dollars have decreased, BayBio has made member introductions to new sources of capital such as corporate venture, disease foundations and sovereign funds. Additionally, through workshops on how to apply for government grants and the Therapeutic Tax Credits, BayBio has helped the region become the largest recipient of NIH and other federal dollars.
The Entrepreneur and Investor Roundtables is a unique event designed to facilitate introductions, dialogue and connections between life science entrepreneurs and investors. This event provides early-stage companies with an accessible first step into the capital markets while providing investors a first look at investable innovations.
BayBio’s Pharma Partnering Day program provides pharmaceutical companies and high quality, small therapeutic companies the opportunity to participate in targeted one-on-one meetings, providing access to novel technologies for co-development.
The BayBio Institute periodically provides life science start-ups and entrepreneurs with information on strategic, operational and financial resources, such as how to apply for SBIR/STTR grants, refining investor pitches, and other resource-specific workshops.